Role of the First N-Terminal Basic Cluster of Human Lactoferrin (R2R3R4R5) in the Interactions with the Jurkat Human Lymphoblastic T-Cells

  • D. Legrand
  • P. H. C. van Berkel
  • V. Salmon
  • H. A. van Veen
  • M. C. Slomianny
  • J. H. Nuijens
  • G. Spik
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 443)


We previously characterized a receptor of Mr 105,000 for human lactoferrin (hLf) on Jurkat human lymphoblastic T-cells. To delineate the role of R2R3R4R5 of hLf in the interaction with cells, we studied the binding of hLf variants obtained either by tryptic proteolysis (hLf−2N, hLf−3N and hLf−4N)or by mutagenesis (rhLf−5N). Consecutive removal of N-terminal arginine residues from hLf progressively increased the binding affinity but decreased the number of binding sites on the cells. The binding parameters of bovine Lf and native hLf did not differ, whereas the binding parameters of murine Lf resembled those of rhLLf−5N. Culture of Jurkat cells in the presence of chlorate, which inhibits sulfation, reduced the number of binding sites for both native hLf and hLf−3N but not for rhLf−5N indicating that the hLf binding sites include sulfated molecules. The results suggest that the interaction of hLf with about 80,000 binding sites per Jurkat cell, mainly sulfated molecules, is dependent on R2R3R4, but not on R5. Interaction with about 20,000 binding sites per cell, presumably the hLf receptor, does not require the first N-terminal basic cluster of hLf. We conclude that the deletion of R2–R5 from hLf may serve to modulate the nature of its binding to cells and thereby its effects on cellular physiology.


Jurkat Cell Basic Cluster Chylomicron Remnant Sodium Chlorate Human Lactoferrin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mikogami, T., Heyman, M., Spik, G. and Desjeux, J.F. (1994) Am. J. Physiol. 267, G308–G315PubMedGoogle Scholar
  2. 2.
    Rochard, E., Legrand, D., Lecocq, M., Hammelin, R., Crépin, M., Montreuil, J. and Spik, G. (1992) Anticancer Res. 1, 2047–2052Google Scholar
  3. 3.
    McAbee, D.D. and Esbensen, K. (1991) J. Biol. Chem. 226, 23624–23631Google Scholar
  4. 4.
    Ziere, G.J., van Dijk, M.C.M., Bijsterbosch, M.K. and van Berkel, T.J.C. (1992) J. Biol. Chem. 267, 11229–11235PubMedGoogle Scholar
  5. 5.
    Birgens, H.S., Karle, H., Hansen, N.E. and Kristensen, L. (1984) Scand. J. Haematol. 33, 275–280PubMedCrossRefGoogle Scholar
  6. 6.
    Mazurier, J., Legrand, D., Hu, W.L., Montreuil, J. and Spik, G. (1989) Eur. J. Biochem. 179, 481–487PubMedCrossRefGoogle Scholar
  7. 7.
    Leveugle, B., Mazurier, J., Legrand, D., Mazurier, C., Montreuil, J. and Spik, G. (1993) Eur. J. Biochem., 213, 1205–1211PubMedCrossRefGoogle Scholar
  8. 8.
    Appelmeik, B.J., An, Y.Q., Geerts, M., Thijs, B.G., de Boer, H.A., MacLaren, D.M. de Graaff, J. and Nuijens, J.H. (1994) Infect. Immun. 62, 2628–2632Google Scholar
  9. 9.
    Elass-Rochard, E., Roseanu, A., Legrand, D., Trif, M., Salmon, V., Motas, C., Montreuil, J. and Spik, G. (1995) Biochem. J. 312, 839–845PubMedGoogle Scholar
  10. 10.
    Mann, D.M., Romm, E. and Migliorini, M. (1994) J. Biol. Chem. 269, 23661–23667PubMedGoogle Scholar
  11. 11.
    Wu, H.F., Monroe, D.M. and Church, F.C. (1995) Arch. Biochem. Biophys. 317, 85–92PubMedCrossRefGoogle Scholar
  12. 12.
    Hutchens, T.W, Henry, J.F. and Yip, T.T. (1991) Pediatr. Res. 29, 243–250PubMedCrossRefGoogle Scholar
  13. 13.
    Jorieux, S., Mazurier, J., Montreuil, J. and Spik, G. (1985) Prot. Biol. Fluids 32, 115–118Google Scholar
  14. 14.
    van Berkel, P.H.C., Geerts, M.E.J., van Veen, H.A., Mericskay, M., de Boer, H.A. and Nuijens, J.H., (1997) Biochem. J., 328, 145–151PubMedGoogle Scholar
  15. 15.
    van Berkel, P.H.C., Geerts, M.E., van Veen, N.A., Kooiman, P.M., Pieper, F.R., de Boer, H.A. and Nuijens, J.H. (1995) Biochem. J. 312, 107–114PubMedGoogle Scholar
  16. 16.
    Metz-Boutigue, M.H., Jollès, J., Mazurier, J., Schoentgen, F., Legrand, D., Spik, G., Montreuil, J. and Jollès, R. (1984) Eur. J. Biochem. 145, 659–676PubMedCrossRefGoogle Scholar
  17. 17.
    Rey, M.W., Woloshuk, S.L., de Boer, H.A. and Pieper, F.R. (1990) Nucleic Acids Res. 18, 5288PubMedCrossRefGoogle Scholar
  18. 18.
    Pierce, A., Colavizza, D., Benaïssa, M., Maes, P., Tartar, A., Montreuil, J. and Spik, G. (1991) Eur. J. Biochem. 196, 177–184PubMedCrossRefGoogle Scholar
  19. 19.
    Pentecost, B.T. and Teng, C.T. (1987) J. Biol. Chem. 262, 10134–10139PubMedGoogle Scholar
  20. 20.
    Legrand, D., Mazurier, J., Elass, A., Rochard, E., Vergoten, G., Maes, P., Montreuil, J. and Spik, G. (1992) Biochemistry 31, 9243–9251PubMedCrossRefGoogle Scholar
  21. 21.
    Zimecki, M., Mazurier, J., Machnicki, M., Wieczorek, Z., Montreuil, J. and Spik, G. (1991) Immun. Lett. 30, 377–382CrossRefGoogle Scholar
  22. 22.
    Ziere, G.J., Kruit, J.K., Bijsterbosch. M.K. and van Berkel, T.J.C. (1993) J. Biol. Chem. 268, 27069–27075PubMedGoogle Scholar
  23. 23.
    Huettinger, M., Retzek, H., Hermann, M. and Goldenberg, H. (1992) J. Biol. Chem. 267, 18551–18557PubMedGoogle Scholar
  24. 24.
    Keller, K.M., Brauer, P.R. and Keller, J.M. (1989) Biochemistry 28, 8100–8107PubMedCrossRefGoogle Scholar
  25. 25.
    Spik, G., Strecker, G., Fournet, B., Bouquelet, S., Montreuil, J., Dorland, L., van Halbeek, H., Vliegenthart, J.F.G. (1982) Eur. J. Biochem. 121, 413–419PubMedCrossRefGoogle Scholar
  26. 26.
    Legrand, D., van Berkel, P.H.C., Salmon, V., van Veen, H.A., Slomianny, M.-C., Nuijens, J.H. and Spik, G. (1997) Biochem. J. 327, 841–846PubMedGoogle Scholar
  27. 27.
    Salmon, V., Legrand, D., Georges, B., Slomianny, M.-C., Coddeville, B. and Spik, G. (1997) Protein Expression Purif. 9, 203–210CrossRefGoogle Scholar
  28. 28.
    Bi, B.Y., Liu, J.L., Legrand, D., Roche, A.C., Capron, M., Spik, G. and Mazurier, J. (1996) Eur. J. Cell Biol. 69, 288–296PubMedGoogle Scholar
  29. 29.
    Scatchard, G. (1949) Ann. N.Y. Acad. Sci. 51, 660–672CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • D. Legrand
    • 1
  • P. H. C. van Berkel
    • 2
  • V. Salmon
    • 1
  • H. A. van Veen
    • 2
  • M. C. Slomianny
    • 1
  • J. H. Nuijens
    • 2
  • G. Spik
    • 1
  1. 1.Laboratoire de Chimie Biologique and U.M.R. du CNRS n°111Université des Sciences et Technologies de LilleVilleneuve d’Ascq, CedexFrance
  2. 2.Pharming BVLeidenThe Netherlands

Personalised recommendations